Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
J Hosp Infect ; 125: 21-27, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35429583

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has become a major public health problem. Dental procedures that generate aerosols are considered to impose a high risk of infection; therefore, dental professionals, such as dentists and dental hygienists, may be at high risk of viral transmission. However, few studies have reported COVID-19 clusters in dental care settings. AIM: To investigate whether dental and oral/maxillofacial procedures are associated with the occurrence of COVID-19 clusters and measures taken to prevent nosocomial infection in dental clinics. METHODS: An online questionnaire survey on clinical activities (administrative control), infection control measures (environmental/engineering control, personal protective equipment, etc.), and confirmed or probable COVID-19 cases among patients and clinical staff was administered to the faculties of the dental and oral/maxillofacial surgical departments of university hospitals. FINDINGS: Fifty-one faculty members completed the questionnaire. All members were engaged in the treatment of dental and oral surgical outpatients and actively implemented standard precautions. Fourteen faculty members treated patients with COVID-19, but no infections transmitted from the patients to the medical staff were observed. In seven facilities, patients were found to have the infection after treatment (medical staff came in close contact), but there was no transmission from patients to medical staff. Four facilities had medical staff with infections, but none of them exhibited disease transmission from staff to patients. CONCLUSION: COVID-19 clusters are unlikely to occur in dental and oral surgical care settings if appropriate protective measures are implemented.


Subject(s)
COVID-19 , Pandemics , Hospitals, University , Humans , Japan/epidemiology , Pandemics/prevention & control , Personal Protective Equipment , SARS-CoV-2 , Surveys and Questionnaires
2.
Int J Oral Maxillofac Surg ; 51(10): 1264-1272, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35125267

ABSTRACT

The aim of this study was to evaluate the therapeutic efficacy and safety of proton beam therapy combined with retrograde intra-arterial infusion chemotherapy in elderly patients with locally advanced oral cancer. Between February 2009 and October 2019, 42 oral cancer patients aged ≥75 years were treated with this therapy. Median age was 80 years (range 75-90 years) and the median follow-up duration was 39 months (range 2-106 months). Of the 42 patients, 34 (81%) were diagnosed with stage IV cancer. The 3-year overall survival, local control, progression-free survival, and disease-specific survival rates were 56%, 69%, 32%, and 67%, respectively. Regarding acute toxicities, grade 3 neutropenia was observed in six patients (14%), anaemia in five (12%), acute kidney injury in one (2%), and oral mucositis in 18 (42%). Late toxicities of grade 3 were observed in seven patients: dysphagia in six (14%) and osteonecrosis of the jaw in one (2%). This study showed that proton beam therapy combined with retrograde intra-arterial infusion chemotherapy was effective for elderly patients with oral cancer, and toxicities were tolerable and manageable. The study findings suggest that this therapy is a potential treatment option for elderly oral cancer patients with difficulty in surgery and systemic chemotherapy.


Subject(s)
Carcinoma, Squamous Cell , Mouth Neoplasms , Proton Therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/therapy , Child , Cisplatin/adverse effects , Humans , Infusions, Intra-Arterial , Mouth Neoplasms/drug therapy , Treatment Outcome
6.
J Stomatol Oral Maxillofac Surg ; 121(5): 589-591, 2020 11.
Article in English | MEDLINE | ID: mdl-32156672

ABSTRACT

Foreign body-induced sialolith is very rare. We report minimally invasive sialendoscopic removal of gold filament thread-induced sialolith in the duct of the parotid gland. A 51-year-old woman with recurrent swelling of the left parotid gland was referred to our hospital. She had undergone insertion of 0.1-mm-diameter gold filament threads into the subdermal skin for facial rejuvenation previously. Computed tomography showed many gold filament threads in the subdermal skin and a sialolith (9.5×4.1×7.9mm) including a gold filament thread in the left parotid duct. The patient underwent endoscopic removal of the sialolith using a 1.6-mm-diameter sialendoscope and Holmium laser under general anesthesia. The sialolith was completely removed with basket and forceps after laser fragmentation, and the broken fragments contained gold filament thread. There was no recurrence of parotid gland swelling after the removal.


Subject(s)
Salivary Gland Calculi , Endoscopy , Female , Gold , Humans , Middle Aged , Parotid Gland , Salivary Ducts/surgery , Salivary Gland Calculi/diagnosis , Salivary Gland Calculi/etiology , Salivary Gland Calculi/surgery
7.
Int J Oral Maxillofac Surg ; 49(7): 901-907, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31889580

ABSTRACT

The double splint method is considered the gold standard for maxillary repositioning, but the procedure is lengthy and prone to error. Recent splintless methods have shown high repositioning accuracy; however, high costs and technical demands make them inaccessible to many patients. Therefore, a new cost-effective method of mandible-independent maxillary repositioning using pre-bent locking plates is proposed. Plates are bent on maxillary models in the planned position prior to surgery. The locations of the plate holes are replicated during surgery using osteotomy guides made from thermoplastic resin sheets. Pre-bent plates are subsequently fitted onto the maxilla, and plate holes are properly set to reposition the maxilla. The purpose of this study was to evaluate the accuracy of this method for maxillary repositioning and the reproducibility of the plate holes. Fifteen orthognathic surgery patients were evaluated retrospectively by superimposing preoperative simulations over their postoperative computed tomography models. The median deviations in maxillary repositioning and plate hole positioning between the preoperative plan and postoperative results were 0.43mm (range 0-1.55mm) and 0.33mm (range 0-1.86mm), respectively. There was no significant correlation between these deviations, suggesting that the method presented here allows highly accurate and reliable mandible-independent maxillary repositioning.


Subject(s)
Orthognathic Surgical Procedures , Surgery, Computer-Assisted , Humans , Imaging, Three-Dimensional , Mandible , Maxilla , Pilot Projects , Reproducibility of Results , Retrospective Studies
8.
Int J Oral Maxillofac Surg ; 46(6): 682-686, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28209378

ABSTRACT

Facial nerve paralysis (FNP) after super-selective intra-arterial chemotherapy (SSIAC) is a relatively rare local side effect of SSIAC to the maxillary artery (MA) or the middle meningeal artery (MMA). The incidence and prognosis of FNP after SSIAC in 381 patients with oral cancer (133 with catheterization of the MA, 248 without) was investigated retrospectively. Only three patients (two male and one female) had FNP, for an incidence of 0.8%. All patients with FNP had undergone catheterization of the MA, and the incidence of FNP in this group was 2.3% (3/133). One of the three patients with FNP had paralysis of the third branch of the trigeminal nerve. FNP occurred a mean of 8.7 days (range 5-11 days) after initial SSIAC, and the mean total dose of cisplatin was 55.8mg (range 42.5-67.2mg) and of docetaxel was 25.4mg (range 17.0-33.6mg). FNP resolved completely a mean of 12.7 months (range 6-19 months) after onset. Because the administration of anticancer agents via the MA or MMA carries a risk of FNP, this information will be useful when obtaining informed consent from patients before treatment.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Catheterization/adverse effects , Facial Paralysis/chemically induced , Mouth Neoplasms/drug therapy , Aged , Facial Paralysis/epidemiology , Female , Humans , Incidence , Male , Maxillary Artery , Meningeal Arteries , Middle Aged , Mouth Neoplasms/radiotherapy , Prognosis , Retrospective Studies
9.
Strahlenther Onkol ; 190(2): 181-5, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24264464

ABSTRACT

PURPOSE: The aim of this study was to review the efficacy and toxicity of radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy in the treatment of gingival carcinoma. METHODS AND MATERIALS: In all, 34 patients (21 men and 13 women) with squamous cell carcinoma of the gingiva underwent radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy. Treatment consisted of daily external irradiation and concurrent retrograde superselective intra-arterial infusion with cisplatin and docetaxel. A median total dose of 60 Gy in 30 fractions was delivered to tumors. RESULTS: Of the 34 patients, 29 (85 %) achieved a complete response (CR) and 5 had residual tumors. Of the 29 patients with a CR, 2 had local recurrences and 1 had distant metastasis 1-15 months after treatment. Twenty-six of the 36 patients had survived at a median follow-up time of 36 months (range 12-79 months); 4 died of cancer and 4 died of non-cancer-related causes. At both 3 and 5 years after treatment, the overall survival rates were 79 % and the cause-specific survival rates were 85 %. Osteoradionecrosis of the mandibular bone only developed in 1 patient after treatment. CONCLUSION: Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy was effective and safe in the treatment of gingival carcinoma. This treatment may be a promising curative and organ-preserving treatment option for gingival carcinoma.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma, Squamous Cell/therapy , Chemoradiotherapy , Gingival Neoplasms/therapy , Infusions, Intra-Arterial , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Cisplatin/administration & dosage , Combined Modality Therapy , Disease Progression , Docetaxel , Female , Gingival Neoplasms/mortality , Gingival Neoplasms/pathology , Humans , Male , Middle Aged , Neoplasm Staging , Organ Sparing Treatments , Survival Rate , Taxoids/administration & dosage
10.
Aust Dent J ; 58(4): 424-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24320897

ABSTRACT

Cervicofacial subcutaneous emphysema is a rare complication of dental procedures. Although most cases of emphysema occur incidentally with the use of a high-speed air turbine handpiece, there have been some reports over the past decade of cases caused by dental laser treatment. Emphysema as a complication caused by the air cooling spray of a dental laser is not well known, even though dental lasers utilize compressed air just as air turbines and syringes do. In this study, we comprehensively reviewed cases of emphysema attributed to dental laser treatment that appeared in the literature between January 2001 and September 2012, and we included three such cases referred to us. Among 13 cases identified in total, nine had cervicofacial subcutaneous and mediastinal emphysema. Compared with past reviews, the incidence of mediastinal emphysema caused by dental laser treatment was higher than emphysema caused by dental procedure without dental laser use. Eight patients underwent CO2 laser treatment and two underwent Er:YAG laser treatment. Nine patients had emphysema following laser irradiation for soft tissue incision. Dentists and oral surgeons should be cognizant of the potential risk for iatrogenic emphysema caused by the air cooling spray during dental laser treatment and ensure proper usage of lasers.


Subject(s)
Laser Therapy/adverse effects , Mediastinal Emphysema/etiology , Subcutaneous Emphysema/etiology , Dental Care/adverse effects , Face , Humans , Laser Therapy/instrumentation , Lasers, Gas/adverse effects , Lasers, Solid-State/adverse effects , Male , Middle Aged , Neck
11.
Int J Oral Maxillofac Surg ; 42(5): 627-31, 2013 May.
Article in English | MEDLINE | ID: mdl-23245701

ABSTRACT

The aim of this experiment was to evaluate the histological effects of zoledronic acid on the periodontal space in rats. 40 male Wistar rats were divided into three zoledronic acid groups and a control group. Zoledronic acid was injected subcutaneously at doses of 10, 50, or 500 µg/kg once a week for 3 weeks. The rats were killed 1 or 9 weeks after the last injection. Histological examination of the periodontal space around the incisor tooth revealed that zoledronic acid did not inhibit tooth development. In the rats killed 1 week after treatment discontinuation, the periodontal space gradually narrowed in response to increasing zoledronic acid doses, and the changes were statistically significant according to ANOVA but not according to ANOVA with post hoc tests. The changes persisted in the high-dose zoledronic acid group despite zoledronic acid discontinuation, with significant differences identified by ANOVA and ANOVA with post hoc tests. Therefore, although zoledronic acid had an insignificant effect on tooth development, it had a significant effect on the periodontal space when high doses were administered. The results of this experiment may provide useful information for future investigations on the role of zoledronic acid in the osteonecrosis of the jaw.


Subject(s)
Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Imidazoles/adverse effects , Periodontium/drug effects , Alveolar Process/drug effects , Alveolar Process/pathology , Anatomy, Cross-Sectional , Animals , Bone Density Conservation Agents/administration & dosage , Diphosphonates/administration & dosage , Dose-Response Relationship, Drug , Imidazoles/administration & dosage , Incisor/drug effects , Incisor/growth & development , Incisor/pathology , Injections, Subcutaneous , Male , Mandible/drug effects , Mandible/pathology , Periodontal Ligament/drug effects , Random Allocation , Rats , Rats, Wistar , Time Factors , Tooth Socket/drug effects , Tooth Socket/pathology , Zoledronic Acid
12.
Heart ; 94(9): 1162-5, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18032460

ABSTRACT

OBJECTIVES: We evaluated the predictors of recurrent restenosis and the impact of lesion length and vessel size on outcomes in patients treated with routine sirolimus-eluting stent (SES) implantation for in-stent restenosis (ISR) of bare-metal stent (BMS). METHODS: In this study, 250 consecutive patients with 275 lesions after SES implantation for ISR of BMS were enrolled. Follow-up angiogram was obtained in 239 patients with 258 lesions eight months after implantation (follow-up rate: 95.6%). We compared characteristics of patients and lesions between the two groups (the recurrent restenosis group and the no-restenosis group). RESULTS: Recurrent restenosis was angiographically documented in 43 lesions (16.7%). Recurrent restenosis was found in 30.4% with small vessel lesions (reference diameter of less than 2.5 mm, 92 lesions) and 23% with the diffuse type lesions (106 lesions). Seventy-two per cent of patients had a focal pattern of recurrent restenosis. Previously recurrent ISR lesions (odds ratio (OR) 1.94, 95% confidence interval (CI) 0.94 to 4.06, p = 0.05), reference diameter of less than 2.5 mm (OR 2.41, CI 1.05 to 5.41, p = 0.03), diffuse type restenosis (OR 4.48, CI 2.12 to 9.94, p = 0.0001) and dialysis patients (OR 4.72, CI 1.42 to 15.7, p = 0.01) were independent predictors of recurrent restenosis. CONCLUSIONS: Small vessels, diffuse type restenosis and dialysis patients were still the predictors of recurrent restenosis in patients treated with SES for ISR of BMS.


Subject(s)
Coronary Restenosis/pathology , Coronary Vessels/pathology , Drug-Eluting Stents , Immunosuppressive Agents/therapeutic use , Sirolimus/therapeutic use , Aged , Blood Vessel Prosthesis Implantation/methods , Coronary Angiography , Coronary Restenosis/drug therapy , Coronary Restenosis/surgery , Female , Humans , Male , Middle Aged , Multivariate Analysis , Prognosis
13.
J Am Chem Soc ; 123(47): 11577-85, 2001 Nov 28.
Article in English | MEDLINE | ID: mdl-11716711

ABSTRACT

A novel strategy for the diversity-oriented synthesis of multisubstituted olefins, where 2-pyridyldimethyl(vinyl)silane functions as a versatile platform for olefin synthesis, is described. The palladium-catalyzed Heck-type coupling of 2-pyridyldimethyl(vinyl)silanes with organic iodides took place in the presence of Pd2(dba)3/tri-2-furylphosphine catalyst to give beta-substituted vinylsilanes in excellent yields. The Heck-type coupling occurred even with alpha- and beta-substituted 2-pyridyldimethyl(vinyl)silanes. The one-pot double Heck coupling of 2-pyridyldimethyl(vinyl)silane took place with two different aryl iodides to afford beta,beta-diarylated vinylsilanes in good yields. The palladium-catalyzed Hiyama-type coupling of 2-pyridyldimethyl(vinyl)silane with organic halides took place in the presence of tetrabutylammonium fluoride to give di- and trisubstituted olefins in high yields. The sequential integration of Heck-type (or double Heck) coupling and Hiyama-type coupling produced the multisubstituted olefins in regioselective, stereoselective, and diversity-oriented fashions. Especially, the one-pot sequential Heck/Hiyama coupling reaction provides an extremely facile entry into a diverse range of stereodefined multisubstituted olefins. Mechanistic considerations of both Heck-type and Hiyama-type coupling reactions are also described.


Subject(s)
Alkenes/chemical synthesis , Pyridines/chemistry , Silanes/chemistry , Catalysis , Chemistry, Organic/methods , Hydrocarbons, Iodinated/chemistry , Iodobenzenes/chemistry , Palladium/chemistry
14.
J Org Chem ; 66(11): 3970-6, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11375022

ABSTRACT

A novel methodology for the deprotonation of a methyl group on silicon has been developed. This newly developed alpha-lithiation protocol is based on the intramolecular pyridyl group coordination to stabilize the alpha-silyl carbanion together with the inherent silicon alpha effect. It was found that the deprotonation (t-BuLi/Et(2)O/-78 degrees C) occurs with 2-pyridyltrimethylsilane but not with other related silanes such as phenyltrimethylsilane, 3-pyridyltrimethylsilane, and 4-pyridyltrimethylsilane. It seems that this deprotonation proceeded through the agency of the complex-induced proximity effect (CIPE) of a 2-pyridyl group on silicon. (1)H NMR analysis of (2-pyridyldimethylsilyl)methyllithium revealed the intramolecular coordination of a pyridyl group to lithium. (2-Pyridyldimethylsilyl)methyllithium was found to react with chlorosilanes, hydrosilanes, chlorostannanes, bromine, iodine, organic bromides, aldehydes, and ketones in good to excellent yields. The resultant adducts were further oxidized with H(2)O(2)/KF to give the corresponding alcohols in excellent yields. Thus, this two-step transformation provides an efficient method for the nucleophilic hydroxymethylation.

15.
No Shinkei Geka ; 28(10): 885-9, 2000 Oct.
Article in Japanese | MEDLINE | ID: mdl-11070909

ABSTRACT

A 61-year-old man was admitted to our hospital for mild left hemiparesis and speech disturbance. An initial angiogram revealed occlusion of the right internal carotid artery (ICA) but with sufficient collateral flow by compensated the contralateral carotid artery. Severe stenosis (70%) in the intracavernous (C4-5) portion was identified in the left ICA. Cerebral blood flow was remarkably decreased in both hemispheres. The patient's hemiparesis fluctuated according to the systemic blood pressure in such a manner that induced hypertension therapy was mandatory. On the 19th hospital day, we performed stenting of the left ICA stenosis using a coronary stent. A flexible coronary stent, NIR PRIMO stent 3.0 mm/16 mm (SCIMED, Boston Scientific) was deployed after the predilatation (2.5 mm/10 atm). The initial 70% stenosis was reduced to 6% after the postdilatation (3.75 mm/8 atm). The neurological status was stable after the procedure and we stopped the induced hypertension therapy the next day. We consider that intracranial artery stenting will be a common therapeutic modality in the near future.


Subject(s)
Carotid Stenosis/surgery , Coronary Vessels/surgery , Stents , Carotid Artery, Internal , Carotid Stenosis/diagnostic imaging , Humans , Male , Middle Aged , Tomography, Emission-Computed, Single-Photon
16.
Jpn Circ J ; 64(10): 805-7, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11059627

ABSTRACT

A new enzyme-linked immunosorbent assay can detect 10 pg/ml of human hepatocyte growth factor (HGF). Circulating HGF was significantly higher in patients with unstable angina (296+/-184 pg/ml, mean+/-SD, n=36) than in healthy volunteers (201+/-64 pg/ml, n=250, p<0.0001). Individual concentrations exceeded the mean control value +2 SD (329 pg/ml) in 12 of the 36 (33%) patients with unstable angina. The present study indicates that this new, sensitive HGF assay can successfully detect thrombosis in patients with unstable angina.


Subject(s)
Angina, Unstable/diagnosis , Biomarkers/blood , Coronary Thrombosis/diagnosis , Hepatocyte Growth Factor/blood , Adolescent , Adult , Aged , Aged, 80 and over , Angina, Unstable/blood , Coronary Thrombosis/blood , Creatine Kinase/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Troponin T/blood
17.
Oral Dis ; 6(4): 256-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10918565

ABSTRACT

A 16-year-old male was evaluated for a 1-month history of alveolar bone resorption, which had been treated with endodontics by a neighborhood dentist. Intraoral examination showed slight gingival swelling and teeth mobility. However, no tumor mass was seen. The panoramic image showed resorption of alveolar bone and loss of teeth lamina dura. Because he complained of general fatigue, he was introduced to the internist. Biopsies of gingiva and bone marrow aspiration revealed a massive proliferation of lymphoblasts expressing CD10, 19, 20 and HLA-DR antigens on the surface. Their karyotypes were abnormal; 46, XY, t (8;14) (q24;q32). Accordingly, he was diagnosed as Burkitt's lymphoma, and received intensive chemotherapy which relieved his symptoms and decreased his tumor. However, his disease soon became refractory to chemotherapy, and he died 11 weeks after the onset.


Subject(s)
Alveolar Bone Loss/etiology , Burkitt Lymphoma/complications , Jaw Neoplasms/complications , Adolescent , Antigens, CD19/analysis , Antigens, CD20/analysis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Fatal Outcome , Follow-Up Studies , Gingival Diseases/etiology , HLA Antigens/analysis , Humans , Male , Neprilysin/analysis , Tooth Mobility/etiology
18.
Interv Neuroradiol ; 6 Suppl 1: 181-5, 2000 Nov 30.
Article in English | MEDLINE | ID: mdl-20667244

ABSTRACT

SUMMARY: We performed carotid stenting with Wallstent for 22 cases. The mean stenosis was 74.3 +/- 11.2% before stenting and 14.2 +/- 8.8% after stenting. The technical success (< 40% residual stenosis) was 100%. We experienced 2 embolic complications (one TIA and one minor stroke). Permanent neurological deficits were not encountered in all the patients (0%). Restenosis was observed in 2 cases (12.5%). The both lesions revealed intimal hyperplasia on intravascular ultrasound (IVUS). MRI diffusion weighted study showed that distal embolism happened more often (46.2%) than we expected although most of them were asymptomatic.We must wait for the long term result to conclude that carotid stenting has become one of the treatment modalities.

19.
No Shinkei Geka ; 27(9): 817-23, 1999 Sep.
Article in Japanese | MEDLINE | ID: mdl-10478342

ABSTRACT

We reported the preliminary results of percutaneous transluminal angioplasty (PTA) supported with a self-expanding stent (Wallstent) for the cervical internal carotid artery (i.c.) stenosis in 6 patients (7 lesions). All were male aged from 60 to 79 (mean 70.8). Three patients were symptomatic and 3 were asymptomatic. The procedure was attempted in patients with severe i.c. stenosis according to criteria of NASCET, ECST or ACAS studies and with high risk if carotid endarterectomy (CEA) were performed. In all cases, vascular access was from the femoral artery and angioplasty was performed without cerebral protection. Successful angioplasty was obtained in all cases with no mortality. Stenosis was improved from 82.7% (74-90%) to 17.4% (10-33%). Perioperative complications were seen in only one case with TIA during the postdilatation period, which was supposed to be due to a distal embolism. The preliminary results of PTA supported with self-expanding stent for severe i.c. stenosis were excellent. These results suggested that some patients with severe i.c. stenosis can be treated safely and effectively by stent-supported PTA. However, it is necessary to mark the indications clear and strict, and to follow up these lesions after the procedure, because of the possibility of perioperative ischemic complications and restenosis.


Subject(s)
Angioplasty, Balloon, Coronary , Carotid Stenosis/therapy , Stents , Aged , Carotid Artery, Internal , Humans , Male , Middle Aged , Treatment Outcome
20.
Crit Rev Diagn Imaging ; 39(2-3): 115-258, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9589841

ABSTRACT

1. High-resolution MRCP is a noninvasive imaging modality for depicting the pancreatobiliary tree. The imaging quality of high-resolution MRCP is satisfactory. MRCP can demonstrate dilation, stenosis, and intraductal filling defects of both the biliary tract and the pancreatic duct, which meets the clinical demand for pancreatobiliary imaging. 2. MRCP was successful in almost all the patients. However, the causes of MRCP failure were patient motion, irregular respiratory rhythm, severe pneumobilia, and massive ascitic fluid. 3. When only MIP reconstructed images were used for interpretation, small intraductal filling defects such as a gallstone can be missed. In combination with coronal source images, the ability to detect intraductal stones can be increased. 4. Ferrite ammonium citrate (FAC) is useful in suppressing the background signal intensity of gastrointestinal contents so that the ducts can be clearly visualized. The other technique for decreasing the background signal intensity is target MIP postprocessing, which works well for better visualization of the ducts. 5. The degree of ductal narrowing tends to be overestimated with MRCP because of MIP reconstruction artifact and lower spatial resolution of MRCP than ERCP. 6. MRCP has a diagnostic pitfall of a pseudostenosis of extrahepatic ducts, which may lead to a false-positive diagnosis of ductal narrowing. This pitfall may be caused not only by MIP postprocessing artifacts but by gas, surgical metal, and vascular compression of right hepatic artery. There is another diagnostic pitfall that it is difficult to differentiate intraductal mucin from pancreatic fluid in dilate pancreatic ducts, although ERCP identifies mucin as intraductal filling defects.


Subject(s)
Biliary Tract/pathology , Magnetic Resonance Imaging , Pancreas/pathology , Biliary Tract Diseases/diagnosis , Humans , Pancreatic Diseases/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...